Seoul, South Korea

Jae Bum Lee

This inventor holds 2 USPTO granted patents and 6 published patent applications and 1 EPO patent. Top assignee: Icure Bnp Co., Ltd.. Active years: 2022-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jae Bum Lee. Retrieved from https://idiyas.com/inventor/jae-bum-lee-v1erro3m

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 100.0

 

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2022-2023

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations in Oral Pharmaceutical Compositions by Jae Bum Lee

Introduction

Jae Bum Lee is a notable inventor based in Seoul, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of oral drug delivery systems for anticancer agents. With a total of 2 patents, his work aims to improve patient compliance and reduce medical costs associated with cancer treatments.

Latest Patents

One of Jae Bum Lee's latest patents is an "Oral pharmaceutical composition containing pemetrexed and production method thereof." This invention focuses on creating an oral formulation of pemetrexed, a water-soluble anticancer drug, by forming an ion-binding complex with a bile acid derivative. This innovative approach enhances the oral bioavailability of pemetrexed, which is traditionally administered via injection. By providing this drug in capsule or tablet form, the invention alleviates the inconvenience of injections and improves patient adherence to treatment.

Another significant patent is the "Oral drug delivery composition containing oxaliplatin and method for preparing same." This patent describes a composition that includes oxaliplatin, another water-soluble anticancer agent. Similar to his previous work, this invention involves forming an ionic complex with a bile acid derivative to enhance oral absorption. The resulting oral delivery composition aims to improve patient compliance and reduce the challenges associated with injection-based treatments.

Career Highlights

Jae Bum Lee is currently associated with Icure BNP Co., Ltd., where he continues to innovate in the pharmaceutical sector. His work is characterized by a strong focus on improving drug formulations to enhance patient experiences and outcomes.

Collaborations

He collaborates with talented individuals such as Jin Woo Park and Young Ro Byun, contributing to a dynamic research environment that fosters innovation in drug delivery systems.

Conclusion

Jae Bum Lee's contributions to the field of pharmaceuticals, particularly in oral drug delivery systems for anticancer agents, highlight his commitment to improving patient care. His innovative patents pave the way for more accessible and convenient treatment options for patients battling cancer.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…